PIB Headquarters
PIB’S BULLETIN ON COVID-19
|
|
- India’s Cumulative COVID-19 Vaccination Coverage crosses 67.65 Cr
- More than 51.88 lakh Vaccine Doses administered till 7 pm today
- 45,352 new cases in the last 24 hours
- Active cases account for 1.22% of total cases
- India's Active caseload stands at 3,99,778
- Recovery Rate currently at 97.45%
- 34,791 recoveries in the last 24 hours increases Total Recoveries to 3,20,63,616
- Weekly Positivity Rate  less than 3% for last 70 days
- Daily positivity rate reported to be 2.72%
- 52.65 crore Total Tests conducted so far
#Unite2FightCorona#IndiaFightsCorona
PRESS INFORMATION BUREAU
MINISTRY OF INFORMATION & BROADCASTING
GOVERNMENT OF INDIA
COVID-19 Update
India’s Cumulative COVID-19 Vaccination Coverage crosses 67.65 Cr
More than 51.88 lakh Vaccine Doses administered today till 7 pm
More than 74 Lakh doses administered in the last 24 hours
Recovery Rate currently at 97.45%
45,352 New Cases reported in the last 24 hours
India's Active Caseload  is 1.22% of Total Cases
Weekly Positivity Rate  less than 3% for last 70 days
India’s COVID-19 vaccination coverage has crossed 67.65 Crore  today. More than 51.88 lakh  Vaccine Doses have been administered today.
This is as per the 7 pm provisional report. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.
The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:
|
|
Cumulative Vaccine Dose Coverage
|
|
HCWs
|
|
1st Dose
|
|
1,03,60,234
|
|
2nd Dose
|
|
84,47,084
|
|
FLWs
|
|
1st Dose
|
|
1,83,28,369
|
|
2nd Dose
|
|
1,34,51,798
|
|
Age Group 18-44 years
|
|
1st Dose
|
|
26,66,03,686
|
|
2nd Dose
|
|
3,20,41,597
|
|
Age Group 45-59 years
|
|
1st Dose
|
|
13,50,91,616
|
|
2nd Dose
|
|
5,70,00,670
|
|
Over 60 years
|
|
1st Dose
|
|
8,89,03,399
|
|
2nd Dose
|
|
4,62,71,848
|
|
Cumulative 1st dose administered
|
|
51,92,87,304
|
|
Cumulative 2nd dose administered
|
|
15,72,12,997
|
|
Total
|
|
67,65,00,301
Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:
|
|
Date: 3rdSeptember, 2021 
|
|
HCWs
|
|
1st Dose
|
|
242
|
|
2nd Dose
|
|
14,015
|
|
FLWs
|
|
1st Dose
|
|
699
|
|
2nd Dose
|
|
55,656
|
|
Age Group 18-44 years
|
|
1st Dose
|
|
25,52,650
|
|
2nd Dose
|
|
9,78,246
|
|
Age Group 45-59 years
|
|
1st Dose
|
|
6,37,730
|
|
2nd Dose
|
|
4,40,698
|
|
Over 60 years
|
|
1st Dose
|
|
2,90,577
|
|
2nd Dose
|
|
2,18,381
|
|
1st Dose Administered in Total
|
|
34,81,898
|
|
2nd Dose Administered in Total
|
|
17,06,996
|
|
Total
|
|
51,88,894
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.
The recovery of 34,791 patients in the last 24 hours has increased the cumulative tally of recovered patients  to 3,20,63,616.
Consequently, India’s recovery rate stands at 97.45%.
Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 68 consecutive days now.
45,352 new cases were reported in the last 24 hours.
The Active Caseload is presently 3,99,778. Active cases presently constitute 1.22% of the country's total Positive Cases.
The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 16,66,334 tests being conducted. India has so far conducted over 52.65 Cr  cumulative tests.
While testing capacity has been enhanced across the country, Weekly Positivity Rate at 2.66% remains less than 3% for the last 70 days now. The Daily Positivity rate stands at 2.72%. The daily Positivity rate has remained below 5% for 88 consecutive days now.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1751596
Update on COVID-19 Vaccine Availability in States/UTs
More than 65Crore vaccine doses provided to States/UTs
More than 4.36 Crore balance and unutilized vaccine doses still available with States/UTs with 1.20 Crore doses in Pipeline
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply  75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
|
|
VACCINE DOSES
|
|

|
|
SUPPLIED
|
|
65,00,99,080
|
|
PIPELINE
|
|
1,20,95,700
|
|
BALANCE AVAILABLE
|
|
4,36,81,760
More than 65crore vaccine doses have been provided to States/UTs so farthrough Govt of India  and through direct state procurement category.Further, more than 1.20 Crore doses  are in the pipeline.
More than 4.36Cr  balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1751594
India at BRICS Digital Health Summit
Dr. Bharati Pravin Pawar discusses challenges and opportunities during the implementation of Digital Health at the BRICS Ministerial Conclave
“NDHM will streamline digital health and through the issue of Unique Health ID create a single source of truth for facilities and practitioners”
“BRICS Digital Health Platform is the need of the hour. It will provide a repository of evidence-based policy making”
BRICS Digital Health Declaration adopted
At the outset, Dr. Pawar acknowledged that Digital Health has become the priority in wake of COVID 19 Pandemic. She said, “The two waves presented us with unique challenges for which an effective and humane centralized response sensitive to regional needs was warranted. The Digital health was aptly utilized to manage the pandemic and enabled us for a much more scientific and data driven approach for strengthening our response.”
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1751824
Dr. Bharti Pravin Pawar, Minister of State for Health and Family Welfare visits Dr. RML Hospital
The Minister of State for Health and Family Welfare, Dr. Bharti Pravin Pawar, visited Dr. Ram Manohar Lohia Hospital, Delhi today for a review.During this, the Medical Superintendent and other medical officers present there welcomed the Honorable Minister. During the review visit, she first visited the Covid Vaccination Center and interacted with the beneficiaries.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1751784
Department of Biotechnology Mission COVID Suraksha Supported Biological E Limited Novel Covid-19 Vaccine candidate – CORBEVAX receives DCGI approval for Two Clinical Trials"
Active controlled Phase III Clinical trial in Adult population
Phase II/III Paediatric trial in Children and Adolescents 
Biological E. has received Drugs Controller General of India  approval for conducting Phase III Comparator Safety & Immunogenicity trial in adults after Subject Expert Committee’s  review of Phase I and II clinical trials data. Additionally, Biological E. also received approval on 01.09.2021 to initiate the Phase II/III Study to evaluate Safety, Reactogenicity, Tolerability and Immunogenicity of CORBEVAX™ vaccine in Children and Adolescents. The candidate is a RBD protein sub-unit vaccine.
Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1751664
Important Tweets